Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Liver transplant (LT) is the most favorable treatment option for patients with early stage hepatocellular carcinoma (HCC). Numerous attempts have been pursued to establish eligibility criteria and select HCC patients for LT, leading to various systems that essentially integrate clinico-morphological...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonvers, Stéphanie, Tabrizian, Parissa, Melloul, Emmanuel, Dormond, Olivier, Schwartz, Myron, Demartines, Nicolas, Labgaa, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402935/
https://www.ncbi.nlm.nih.gov/pubmed/36033451
http://dx.doi.org/10.3389/fonc.2022.940473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402935/
https://www.ncbi.nlm.nih.gov/pubmed/36033451
http://dx.doi.org/10.3389/fonc.2022.940473

Ejemplares similares